AlphaSense Reflects on Record Award Wins for AI Innovation in 2024

Recognitions Highlight the Company\'s Momentum Heading Into 2025 NEW YORK,Jan. 15,2025--AlphaSense,the leading market intelligence and search platform,today celebrated a landmark year of achievements

COOFANDY Extends Support to Those Impacted by Wildfires in Southern California

NEW YORK,Jan. 15,2025-- In response to the devastating wildfires affecting Southern California,COOFANDY,a designer brand specializing in modern men\'s essentials,has partnered with several apparel bra

NEXTEER'S FACILITY GRAND OPENING IN CHANGSHU, CHINA EXPANDS ADVANCED STEERING PRODUCTION & VALIDATION

Capitalizes on Company\'s APAC Growth Momentum CHANGSHU,China,Jan. 15,2025-- Nexteer Automotive today announced the grand opening of its new facility in Changshu,Jiangsu Province,as a strategic expan

mF International Limited Honored with Good MPF Employer Award 2023-24

HONG KONG,Jan. 15,2025-- mF International Limited (the "Company" or "mF International") (Nasdaq: MFI),a Hong Kong-based experienced financial trading solutions provider,is proud to

Masdar's Capacity Up By 150% to Over 50GW In Two Years Cementing Place as Global Clean Energy Leader

Masdar\'s operational,under construction and advanced pipeline capacity grew from 20GW to 51GW between 2022 and end of 2024

NEXTBIOMEDICAL Receives IDE Approval from FDA for Nexsphere-F™, an Embolic Microsphere for Use in Genicular Artery Embolization (GAE) for Knee Osteoarthritis: The U.S. RESORB Trial Launches

SEOUL,South Korea,Jan. 15,2025-- NEXTBIOMEDICAL CO.,LTD,a KOSDAQ-listed innovative medical device company in South Korea,proudly announced that it has received Investigational Device Exemption (IDE)

iMotions to Fully Integrate Affectiva's Media Analytics in Order to Establish Consolidated Global Behavioral Research Unit within Smart Eye Group

Combination of Smart Eye subsidiaries strengthens products and services,further enabling commercial and academic researchers to gain access to unparalleled insights into human behavior

(Taiwan) CMU Healthcare System and Nobel Laureate Randy Schekman Drive New Frontiers in Exosome Technology

TAICHUNG,Jan. 16,2025-- On November 2,2024,China Medical University (CMU) and Healthcare System hosted the International Forum of Extracellular Vesicles Technology and Novel Therapeutics to highlight

XDS Shoes: How to Find a Shoe Manufacturer

JINJIANG,China,Jan. 14,2025-- With the rising demand for high-quality footwear and private-label customization,finding the right shoe manufacturer has become a critical challenge for businesses in the

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch